PropertyValue
?:abstract
  • This study assessed symptoms and their determinants 1.5–6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, in a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less symptoms after 1.5–6 months than during COVID-19; median (IQR) 0 (0–2) versus 8 (6–11), respectively (p<0.001); 53% of women and 67% of men were symptom free, while 16% reported dyspnoea, 12% loss/disturbance of smell, and 10% loss/disturbance of taste. In multivariable analysis, having persistent symptoms was associated with the number of comorbidities and number of symptoms during the acute COVID-19 phase.
is ?:annotates of
?:creator
?:doi
  • 10.1136/thoraxjnl-2020-216377
?:doi
?:journal
  • Thorax
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/808bf1dfeae25ecb6df473d04586033af25052e2.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7716295.xml.json
?:pmcid
?:pmid
?:pmid
  • 33273028.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study
?:type
?:year
  • 2020-12-03

Metadata

Anon_0  
expand all